Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology

References

• Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., … Weiner, W. J. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80, 496–503.
   PubMed Web of Science ®Google Scholar
• Ballard, C., Piggott, M., Johnson, M., Cairns, N., Perry, R., McKeith, I., … Perry, E. (2000). Delusions associated with elevated muscarinic binding in dementia with lewy bodies. Annals of Neurology, 48, 868–876.
   PubMed Web of Science ®Google Scholar
• Boeve, B. F., Lang, A. E., & Litvan, I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology, 54, S15–9.
   PubMed Web of Science ®Google Scholar
• Boeve, B. F., Silber, M. H., Ferman, T. J., Lucas, J. A., & Parisi, J. E. (2001). Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Movement Disorders : Official Journal of the Movement Disorder Society, 16, 622–630.
   PubMed Web of Science ®Google Scholar
• Boeve, B. F., Silber, M. H., Parisi, J. E., Dickson, D. W., Ferman, T. J., Benarroch, E. E., … Mahowald, M. W. (2003). Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology, 61, 40–45.
   PubMed Web of Science ®Google Scholar
• Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H., & Del Tredici, K. (2004). Stages in the development of parkinson’s disease-related pathology. Cell and Tissue Research, 318, 121–134.
   PubMed Web of Science ®Google Scholar
• Compta, Y., Marti, M. J., Rey, M. J., & Ezquerra, M. (2009). Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry, 80, 578–579.
   PubMed Web of Science ®Google Scholar
• Cooper, A. D., & Josephs, K. A. (2009). Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study. Parkinsonism & Related Disorders, 15, 59–61.
   PubMed Web of Science ®Google Scholar
• Ellmore, T. M., Hood, A. J., Castriotta, R. J., Stimming, E. F., Bick, R. J., & Schiess, M. C. (2010). Reduced volume of the putamen in REM sleep behavior disorder patients. Parkinsonism & Related Disorders, 16, 645–649.
   PubMed Web of Science ®Google Scholar
• Ferman, T. J., Boeve, B. F., Smith, G. E., Lin, S. C., Silber, M. H., Pedraza, O., … Dickson, D. W. (2011). Inclusion of RBD improves the diagnostic classification of dementia with lewy bodies. Neurology, 77, 875–882.
   PubMed Web of Science ®Google Scholar
• Gibb, W. R., Luthert, P. J., & Marsden, C. D. (1989). Corticobasal degeneration. Brain : A Journal of Neurology, 112, 1171–1192.
   PubMed Web of Science ®Google Scholar
• Gibb, W. R., Luthert, P. J., & Marsden, C. D. (1990). Clinical and pathological features of corticobasal degeneration. Advances in Neurology, 53, 51–54.
   PubMedGoogle Scholar
• Harding, A. J., Broe, G. A., & Halliday, G. M. (2002). Visual hallucinations in lewy body disease relate to lewy bodies in the temporal lobe. Brain : A Journal of Neurology, 125, 391–403.
   PubMed Web of Science ®Google Scholar
• Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002). Clinical correlates of selective pathology in the amygdala of patients with parkinson’s disease. Brain : A Journal of Neurology, 125, 2431–2445.
   PubMed Web of Science ®Google Scholar
• Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering-Brown, S., Adamson, J., … Hutton, M. (2001). Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 56, 1702–1706.
   PubMed Web of Science ®Google Scholar
• Hyman, B. T., & Trojanowski, J. Q. (1997). Consensus recommendations for the postmortem diagnosis of alzheimer disease from the national institute on aging and the reagan institute working group on diagnostic criteria for the neuropathological assessment of alzheimer disease. Journal of Neuropathology and Experimental Neurology, 56, 1095–1097.
   PubMed Web of Science ®Google Scholar
• Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., … Mori, E. (1998). Regional cerebral glucose metabolism in dementia with lewy bodies and alzheimer’s disease. Neurology, 51, 125–130.
   PubMed Web of Science ®Google Scholar
• Josephs, K. A., Whitwell, J. L., Boeve, B. F., Knopman, D. S., Petersen, R. C., Hu, W. T., … Jack, C. R. (2010). Anatomical differences between CBS-corticobasal degeneration and CBS-alzheimer’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 25, 1246–1252.
   PubMed Web of Science ®Google Scholar
• Kasanuki, K., Iseki, E., Fujishiro, H., Yamamoto, R., Higashi, S., Minegishi, M., … Arai, H. (2012). Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with lewy bodies. Journal of the Neurological Sciences, 314, 111–119.
   PubMed Web of Science ®Google Scholar
• Kasanuki, K., Josephs, K. A., Ferman, T. J., Murray, M. E., Koga, S., Konno, T., … Dickson, D. W. (2018). Diffuse lewy body disease manifesting as corticobasal syndrome: A rare form of lewy body disease. Neurology, 91, e268–e279.
   PubMed Web of Science ®Google Scholar
• Komori, T. (1999). Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and pick’s disease. Brain Pathology (Zurich, Switzerland), 9, 663–679.
   PubMed Web of Science ®Google Scholar
• Kompoliti, K., Goetz, C. G., Boeve, B. F., Maraganore, D. M., Ahlskog, J. E., Marsden, C. D., … Riley, D. E. (1998). Clinical presentation and pharmacological therapy in corticobasal degeneration. Archives of Neurology, 55, 957–961.
   PubMedGoogle Scholar
• Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984). Diffuse type of lewy body disease: Progressive dementia with abundant cortical lewy bodies and senile changes of varying degree--a new disease? Clinical Neuropathology, 3, 185–192.
   PubMed Web of Science ®Google Scholar
• Kramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., Johnson, J. K., & Miller, B. L. (2003). Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and alzheimer disease. Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology, 16, 211–218.
   PubMedGoogle Scholar
• Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., … Miller, B. L. (2011). Clinicopathological correlations in corticobasal degeneration. Annals of Neurology, 70, 327–340.
   PubMed Web of Science ®Google Scholar
• McKeith, I. G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DLB): Report of the consortium on DLB international workshop. Journal of Alzheimer’s Disease : JAD, 9, 417–423.
   PubMed Web of Science ®Google Scholar
• McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J. P., Weintraub, D., … Kosaka, K. (2017). Diagnosis and management of dementia with lewy bodies: Fourth consensus report of the DLB consortium. Neurology, 89, 88–100.
   PubMed Web of Science ®Google Scholar
• McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., & Feldman, H.; Consortium on DLB. (2005). Diagnosis and management of dementia with lewy bodies: Third report of the DLB consortium. Neurology, 65, 1863–1872.
   PubMed Web of Science ®Google Scholar
• McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., … Perry, R. H. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.
   PubMed Web of Science ®Google Scholar
• Molano, J., Boeve, B., Ferman, T., Smith, G., Parisi, J., Dickson, D., … Petersen, R. (2010). Mild cognitive impairment associated with limbic and neocortical lewy body disease: A clinicopathological study. Brain : A Journal of Neurology, 133, 540–556.
   PubMed Web of Science ®Google Scholar
• Nagahama, Y., Okina, T., Suzuki, N., & Matsuda, M. (2010). Neural correlates of psychotic symptoms in dementia with lewy bodies. Brain : A Journal of Neurology, 133, 557–567.
   PubMed Web of Science ®Google Scholar
• O’Brien, J. T., Colloby, S. J., Pakrasi, S., Perry, E. K., Pimlott, S. L., Wyper, D. J., … Williams, E. D. (2008). Nicotinic alpha4beta2 receptor binding in dementia with lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. NeuroImage, 40, 1056–1063.
   PubMed Web of Science ®Google Scholar
• Papapetropoulos, S., McCorquodale, D. S., Gonzalez, J., Jean-Gilles, L., & Mash, D. C. (2006). Cortical and amygdalar lewy body burden in parkinson’s disease patients with visual hallucinations. Parkinsonism & Related Disorders, 12, 253–256.
   PubMed Web of Science ®Google Scholar
• Perneczky, R., Drzezga, A., Boecker, H., Forstl, H., Kurz, A., & Haussermann, P. (2008). Cerebral metabolic dysfunction in patients with dementia with lewy bodies and visual hallucinations. Dementia and Geriatric Cognitive Disorders, 25, 531–538.
   PubMed Web of Science ®Google Scholar
• Perry, E. K., Marshall, E., Kerwin, J., Smith, C. J., Jabeen, S., Cheng, A. V., & Perry, R. H. (1990). Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in lewy body dementia. Journal of Neurochemistry, 55, 1454–1456.
   PubMed Web of Science ®Google Scholar
• Sanchez-Castaneda, C., Rene, R., Ramirez-Ruiz, B., Campdelacreu, J., Gascon, J., Falcon, C., … Junque, C. (2010). Frontal and associative visual areas related to visual hallucinations in dementia with lewy bodies and parkinson’s disease with dementia. Movement Disorders : Official Journal of the Movement Disorder Society, 25, 615–622.
   PubMed Web of Science ®Google Scholar
• Selikhova, M., Williams, D. R., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J. (2009). A clinico-pathological study of subtypes in parkinson’s disease. Brain : A Journal of Neurology, 132, 2947–2957.
   PubMed Web of Science ®Google Scholar
• Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). Alpha-synuclein in lewy bodies. Nature, 388, 839–840.
   PubMed Web of Science ®Google Scholar
• Uryu, K., Nakashima-Yasuda, H., Forman, M. S., Kwong, L. K., Clark, C. M., Grossman, M., … Neumann, M. (2008). Concomitant TAR-DNA-binding protein 43 pathology is present in alzheimer disease and corticobasal degeneration but not in other tauopathies. Journal of Neuropathology and Experimental Neurology, 67, 555–564.
   PubMed Web of Science ®Google Scholar
• Wilson, R. S., Yu, L., Trojanowski, J. Q., Chen, E. Y., Boyle, P. A., Bennett, D. A., & Schneider, J. A. (2013). TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurology, 70, 1418–1424.
   PubMed Web of Science ®Google Scholar
• Yokota, O., Davidson, Y., Bigio, E. H., Ishizu, H., Terada, S., Arai, T., … Mann, D. M. (2010). Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathologica, 120, 55–66.
   PubMed Web of Science ®Google Scholar